Page 58 - Contract Development News Today

The dietary supplement industry is not only growing rapidly but the market is also evolving through the use of CDMOs.

/PRNewswire/ -- According to Coherent Market Insights, the global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Million in 2022 and is...

/PRNewswire/ -- According to Coherent Market Insights, the global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Million in 2022 and is...

SEATTLE, Sept. 21, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Million in 2022 and is expected to exhibit

/PRNewswire/ --The board of Current Biologics has selected Tom Hochuli as chief executive officer of the startup company, which is focused on providing cell...

/PRNewswire/ -- Lykan Bioscience and RoslinCT, a leader in Contract Development and Manufacturing for cell therapies, announced the formation of its inaugural...

Initiated by the French government and led by the French Treasury, the TIBI label brings together leading institutional investors, who have committed an initial investment of €6 billion, now valued

Novartis plans to invest $300m in next-generation biotherapeutics and to strengthen its expertise in the technical development of biologics.

Dublin, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development & Manufacturing Market Intelligence Report - Global Forecast t

Bharat Biotech has secured approval from CDSCO under Restricted Use in Emergency Situation for its intranasal Covid-19 vaccine, iNCOVACC.